Evaluation of coronary artery disease in potential liver transplant recipients.
TLDR
In assessing LT recipients, a management paradigm of “quadruple assessment” is suggested to include (1) history, examination, and electrocardiogram; (2) transthoracic echocardiograms; (3) functional testing; and (4) where appropriate, direct assessment of CAD.About:
This article is published in Liver Transplantation.The article was published on 2017-03-01 and is currently open access. It has received 52 citations till now. The article focuses on the topics: Liver transplantation & Coronary artery disease.read more
Citations
More filters
Journal ArticleDOI
Multidisciplinary approach to cardiac and pulmonary vascular disease risk assessment in liver transplantation: An evaluation of the evidence and consensus recommendations
Lisa B. VanWagner,Matthew E. Harinstein,James R. Runo,Christopher Darling,Marina Serper,Shelley A. Hall,Jon A. Kobashigawa,Laura L. Hammel +7 more
TL;DR: A critical assessment of the diagnosis of cardiac and pulmonary vascular disease and interventions aimed at managing these conditions in LT candidates is provided to offer guidance for clinicians and identify gaps in knowledge for future investigations.
Journal ArticleDOI
Screening of Cardiovascular Disease in Nonalcoholic Fatty Liver Disease: Whom and How?
TL;DR: The current review article discusses as to which patients with NAFLD to screen and how to screen for CVD, and there is sparse literature regarding the screening forCVD in patients withNAFLD.
Journal ArticleDOI
Pre–Liver Transplant Cardiac Catheterization Is Associated With Low Rate of Myocardial Infarction and Cardiac Mortality
Issa Kutkut,Rayan Jo Rachwan,Lava Timsina,Marwan Ghabril,Marco A. Lacerda,Chandrashekhar A. Kubal,Patrick D.V. Bourdillon,Richard S. Mangus +7 more
TL;DR: This screening protocol for performing CATH based upon predefined risk factors, rather than noninvasive testing alone, is applied to a larger cohort (2010‐2016) to assess post‐LT clinical outcomes.
Journal ArticleDOI
Management of metabolic syndrome and cardiovascular risk after liver transplantation
TL;DR: The management of the components of metabolic syndrome following liver transplantation is discussed and practical stepwise guidance is provided and the need for adequately powered studies for the treatment of metabolic comorbidities in liver transplant recipients is emphasised.
Journal ArticleDOI
Risk stratification of myocardial injury after liver transplantation in patients with computed tomographic coronary angiography-diagnosed coronary artery disease.
Young-Jin Moon,Hye-Mee Kwon,Kyeo-Woon Jung,Hye-Won Jeong,Yong-Seok Park,In-Gu Jun,Jun-Gol Song,Gyu-Sam Hwang +7 more
TL;DR: In conclusion, negative CTCA finding in suspected patients can successfully exclude post‐LT MI, whereas proceeding with invasive angiography is needed to further risk‐stratify in patients with significant C TCA‐diagnosed CAD.
References
More filters
Journal ArticleDOI
Aerobic capacity during cardiopulmonary exercise testing and survival with and without liver transplantation for patients with chronic liver disease
William Bernal,Rosa Martin-Mateos,Miklos Lipcsey,Caroline Tallis,Kyne Woodsford,Mark J. W. McPhail,Christopher Willars,Georg Auzinger,Elizabeth Sizer,Michael A. Heneghan,Simon Cottam,Nigel Heaton,Julia Wendon +12 more
TL;DR: In patients who did not undergo transplantation, impaired AT was predictive of mortality, and in patients undergoing LT, it was related to postoperative hospitalization and survival, and AC should be evaluated as a modifiable factor for improving patient survival whether or not LT is anticipated.
Journal ArticleDOI
Liver Transplantation Outcome in Patients With Angiographically Proven Coronary Artery Disease: A Multi‐Institutional Study
Christopher Wray,J. C. Scovotti,Jonathan M. Tobis,Claus U. Niemann,Raymond M. Planinsic,Ann Walia,James Y. Findlay,Gebhard Wagener,Jacek B. Cywinski,Daniela Markovic,Christopher Hughes,A. Humar,Andrea Olmos,R. Sierra,Ronald W. Busuttil,Randolph H. Steadman +15 more
TL;DR: It is concluded that when current CAD treatment strategies are employed prior to transplant, post‐LT survival is not significantly different between patients with and without obstructive CAD.
Journal ArticleDOI
Cardiac dysfunction during liver transplantation: incidence and preoperative predictors.
Cristina Ripoll,María-Vega Catalina,Raquel Yotti,Luis Olmedilla,José Pérez-Peña,Oreste Lo Iacono,Diego Rincón,Miguel A. García-Fernández,Javier Bermejo,Rafael Bañares +9 more
TL;DR: Abnormal cardiac response is observed during liver transplantation and may be a manifestation of occult cirrhotic cardiomyopathy and is underestimated with usual diagnostic tools and could be related to indirect signs of circulatory dysfunction of advanced liver disease.
Journal ArticleDOI
Association of intraoperative hypotension and pulmonary hypertension with adverse outcomes after orthotopic liver transplantation.
David Reich,Richard K. Wood,Sukru Emre,Carol A. Bodian,Sabera Hossain,Marina Krol,Dennis E. Feierman +6 more
TL;DR: Hemodynamic events are independently associated with adverse outcomes after orthotopic liver transplantation and are temporally associated with donor graft reperfusion.
Journal ArticleDOI
Guidelines for liver transplantation for patients with non-alcoholic steatohepatitis
Philip N. Newsome,Michael Allison,P A Andrews,Georg Auzinger,Christopher P. Day,James Ferguson,P A Henriksen,S G Hubscher,H Manley,Patrick J. McKiernan,Charles Millson,Darius F. Mirza,James Neuberger,Jude A. Oben,Steven M. Pollard,Kerry Simpson,D. Thorburn,Jeremy W. Tomlinson,J S Wyatt +18 more
TL;DR: This guideline for the management of NASH before and after liver transplantation is approved by the British Society of Gastroenterology, the British Association for the Study of Liver and NHS Blood and Transplant.